Navigation Links
Improving Survival Rate Of Lung Cancer Patients

Worldwide, lung cancer accounts for the largest number of new cancer cases and deaths from cancer // annually.
Investigators in an international study found the survival rate of non-small-cell lung cancer patients after its removal improved with cisplatin-based adjuvant chemotherapy. Cisplatin is an anti-neoplastic medication that interferes with the growth of cancer cells and slows their growth and spread in the body.

As part of the International Adjuvant Lung Cancer Trial, researchers randomly assigned 1,867 patients to receive either three or four cycles of cisplatin-based chemotherapy or observation. In addition to cisplatin, the drug etoposide was given to about 56 percent of patients; the drug vinorelbine was given to about 26 percent of patients; vinblastine was given to 11 percent of patients, and vindesine was given to nearly 6 percent of patients. Of the 932 patients assigned to chemotherapy, nearly 73 percent received at least 240 milligrams of cisplatin per square meter of body-surface area.

Results of the study show, after five years, patients assigned to chemotherapy had a significantly higher survival rate at 44.5 percent than those assigned to observation who had a 40.4 survival rate at five years. Patients assigned to chemotherapy also had a significantly higher disease-free survival rate at 39.4 percent than those assigned to observation with 34.3 percent.

According to the study, about 900,000 people worldwide under age 75 receive a lung cancer diagnosis each year and about 75 percent of those patients are candidates for adjuvant chemotherapy. Researchers say their results indicate that roughly 7,000 deaths from non-small-cell carcinoma would be averted annually with the use of adjuvant cisplatin-based chemotherapy.
'"/>




Page: 1

Related medicine news :

1. Plastic Sling Has Proved Successful In Improving Aging Of The Neck
2. Combination Therapy Effective In Improving Lung Cancer Survival
3. Improving Life Expectancy
4. Improving Fertility In Patients With Cervical Cancer
5. Improving The Survival Of Lung Cancer Patients By Blocking The Effects Of Estrogen
6. Improving Lighting Could Bring About A Change In Alzheimers Patients
7. Device For Improving Bone Mass In Osteoporosis
8. Olive Oil Found To Preserve Cardiovascular Health by Improving Function
9. US To Look In To Improving the Elder Care
10. Saw Palmetto Extract No Good In Improving Prostate Health
11. Rahul Mahajans Condition Improving; Vital Parametres Normal
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & ... by Moonlight to raise money for the American Heart Association Heart Walk. Teams of ... will work together to keep their treadmills moving for 5 hours. Treadmills will start ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
Breaking Medicine Technology: